Excellence in Epilepsy Journalism Award
Brussels (ots/PRNewswire) - The 'Excellence in Epilepsy' Journalism Award - an initiative of the International Bureau for Epilepsy (IBE) and UCB - invites journalists from around the world to submit stimulating, informed and compelling news and feature stories on epilepsy. The award seeks to increase awareness and improve understanding of epilepsy. The closing ...
Ingelheim, Germany (ots/PRNewswire) - - Results From Linagliptin Study in Type 2 Diabetes Patients Who Were Inadequately Controlled on Metformin Therapy Alone, Presented at Major Diabetes Meeting Study results presented for the first time in the scientific sessions of this year's American Diabetes ...
San Jose, California (ots/PRNewswire) - - Atmel's Host CryptoAuthentication IC Eliminates the Need for Designers to Understand Complex Cryptographic Protocols and Algorithms Atmel(R) Corporation (Nasdaq: ATML) announced today a "plug-and-play" CryptoAuthentication host-side IC (http://www.atmel.com/products/cryptoauthentication/default.asp)that allows ...
Maidenhead, England (ots/PRNewswire) - - CHMP Recommends Approval of a Continuous Dosing Regimen Option for Enbrel In Plaque Psoriasis, and a New Pre-Filled Pen Delivery Device Today, Wyeth received positive recommendations from the European Committee for Medicinal Products for Human Use (CHMP) for two ...
Basel, Switzerland (ots/PRNewswire) - - Not for US Media - New Ilaris Data in The New England Journal of Medicine Show Rapid Sustained Efficacy in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)(1) - CAPS is a Debilitating Genetic Disorder With Potentially Fatal Complications and Limited ...
Paris and Brisbane, California (ots/PRNewswire) - - Data Highlighted in Plenary Session of 2009 American Society of Clinical Oncology Annual Meeting Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its fully owned subsidiary, BiPar Sciences, today announced results from a randomized Phase 2 clinical trial ...
Mumbai, India (ots/PRNewswire) - - Global Service Helps Customers Ensure Optimal IT Performance Tata Communications, a leading provider of a new world of communications, today announced the launch of Application Performance Visibility Service, a suite of integrated, end-to-end, network and application performance monitoring service with three-tiered ...
Basel, Switzerland (ots/PRNewswire) - - For Non-US Media Only New Phase III study results presented for the first time today at the ninth annual American Transplant Congress 2009 (ATC) demonstrate that doubling the duration of preventive therapy ('prophylaxis') with Valcyte (oral valganciclovir), ...
San Jose, California (ots/PRNewswire) - - SAM3U is Code Portable from Atmel's Established ARM7- and ARM9-based MCU Families Atmel(R) Corporation (Nasdaq: ATML) announced today the SAM3U, the industry's first ARM(R) Cortex(TM)-M3 Flash microcontroller integrating high speed (480 Mbps) USB ...
Basel, Switzerland (ots/PRNewswire) - - PLX4032 (R7204) Phase I Results Offer Hope of First Highly Effective Drug in Melanoma Along With Companion Diagnostic - For Non-US Media Only Roche announced today results from a Phase I study with PLX4032 (R7204) a new, highly selective and promising ...
Orlando, Florida (ots/PRNewswire) - Data from the Phase III ZODIAC(1) study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Results show that the study met its primary endpoint, ...
Basel, Switzerland (ots/PRNewswire) - - For ex-US Media Only - Phase III ATLAS Study Achieves a New Milestone in Treating Advanced Lung Cancer Roche announced today that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer (NSCLC) who received Avastin(R) (bevacizumab) ...
Stichting Shell Reserves Compensation Foundation and Royal Dutch Shell plc
The Hague, The Netherlands (ots/PRNewswire) - The Hague - Today, the Amsterdam Court of Appeals has declared the Non-U.S. Settlement Agreement concerning the recategorisation by Shell of certain of its oil and gas reserves binding. The agreement provides relief in the amount of US$352.6 million to qualifying non-U.S. shareholders who bought Shell shares on any stock exchange outside the United States from 8 April 1999 ...
Basel, Switzerland (ots/PRNewswire) - - RIBBON-1 Study Confirms Benefit of Avastin in Treating HER2-Negative Breast Cancer - For Non-US, Non-UK and Non-Austrian Media Results from the phase III RIBBON-1 study presented today at ASCO showed that patients with advanced HER2-negative breast cancer ...
Collegeville, Pennsylvania (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced preliminary data from two ongoing studies, one evaluating neratinib (HKI-272) in combination with trastuzumab (Herceptin(R), Roche) in HER-2 positive (ErbB-2 positive) breast cancer, and ...
Huizingen, Belgium (ots/PRNewswire) - RealDolmen, the independent single source ICT solutions provider and knowledge company, announces results for the fiscal year ended 31 March 2009, showing good growth across all metrics. Highlights of the year - Turnover up 5,6% - Operational result before nonrecurring items (REBIT) up 7,0 %, with REBIT margins up to 6,0%, despite incurred integration costs - ...
Huntington Beach, California, and Amsterdam (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnostic tests be held to one ...
Ottawa, Canada and Fleurus, Belgium (ots/PRNewswire) - - Site to Provide Fluorodeoxyglucose (F-18 FDG) for use in Earlier Detection of Disease and Therapy Management MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced the opening of a facility in Fleurus, Belgium for the production ...
London (ots/PRNewswire) - - For Healthcare and Pharmaceutical Correspondents Only - NICE Recommends Considering DPP-4 Inhibitors as a Second Line Treatment Option in Appropriate Patients Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A., Canada, and Japan Boehringer Ingelheim announced today that it will become the founding sponsor of the World Stroke Academy, a novel training initiative for stroke professionals being developed by the World Stroke ...
San Jose, California (ots/PRNewswire) - - maXTouch represents the market's most advanced Touchscreen Technology for Mobile Phones, Netbooks and other Electronic Devices Atmel(R) Corporation (Nasdaq: ATML) announced today a new fully integrated capacitive touchscreen technology - maXTouch(TM) - providing touchscreen performance which significantly exceeds ...
Huntington Beach, California and Amsterdam (ots/PRNewswire) - - Agendia Increases U.S. Footprint with Domestic Executive Team and Operations Agendia, a world leader in molecular cancer diagnostics, today announced the opening of its U.S. clinical genomics laboratory in Huntington Beach, CA. The laboratory is fully-licensed and compliant with the Clinical Laboratory Improvements Amendments (CLIA) as administered ...
Basel, Switzerland (ots/PRNewswire) - - Mircera Maintained Haemoglobin Levels in Significantly More Patients With CKD on Dialysis Data from the first head-to-head study in patients with chronic kidney disease (CKD) on dialysis who need treatment for renal anaemia have demonstrated that Mircera(R) (methoxy ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") announced the closing of its (i) private offer to exchange, for each $100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes due 2016 (the "Existing Notes"), one of its units (the "New ...
Abbotsford, Canada (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) is pleased to advise that it has acquired a 49% equity position in Luapula Mineral Ltd, a Zambian registered company which has legal title to 1,000 hectare Prospecting Permit (10 sq kms) within the Luapula area. President and CEO of ICS, Graham Chisholm comments: "This acquisition flows from a MOU between ATJ Natural Resources Ag, of Belize ...
Huntington Beach, California and Amsterdam (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced that leading researchers from Agendia, the University of California San Francisco and the Netherlands Cancer Institute will present data from multiple studies at the American ...
Houston, Texas (ots/PRNewswire) - - Using AVEVA PDMS Technology, Company Fast Tracks World's Largest Energy Projects AVEVA (LSE:AVV) today announced that a major client, Alliance Wood Group Engineering (Alliance) received FIATECH's 2008 Celebration of Engineering & Technology Innovation (CETI) Award in the category of Automated Design. The company uses AVEVA's PDMS solution to plan and execute its ultra-deep ...
Astellas Pharma Europe Limited
Prague (ots/PRNewswire) - - Ointment (Tacrolimus Monohydrate) in a New Twice-Weekly Regimen can Help Prevent Eczema Flares Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. ...
San Jose, California (ots/PRNewswire) - - Subscription license grants Atmel access to ARM Cortex processor IP Atmel(R) Corporation (Nasdaq: ATML) and ARM [(LSE: ARM); (Nasdaq: ARMH)] today announced an extension to their strategic relationship with a new subscription license agreement. Under the terms of the agreement, Atmel gains access to a number of ...
Helsinki (ots/PRNewswire) - - In Vitro Studies Presented at EWMA Conference Compare ConvaTec Dressings With Foams and Alginates (1-4) Researchers with ConvaTec Wound Therapeutics presented a series of in vitro studies demonstrating the advanced features and fluid handling capacity of the company's proprietary dressings containing Hydrofiber(R) Technology ...